November 27, 2023Business Desk

Indian drug manufacturers benefit from Big Pharma interest beyond China

Drugmakers are seeking to limit their reliance on Chinese contractors who produce drugs used in clinical trials and early-stage manufacturing

Source: Unsplash

China has for nearly 20 years been the preferred location for a range of pharmaceutical research and manufacturing services due to the low cost and speed offered by contract drugmakers there

Source: Unsplash

India is seeking a bigger foothold in the pharma services sector to boost sales and reputation for its $42 billion pharmaceuticals industry.

Source: Unsplash

Piramal Pharma has this year received requests from clients for "backward integration to India", which means that even the most basic raw materials are sourced from the country instead of China

Source: Unsplash